The February orchid (Orychophragmus violaceus)-spring maize rotation system is established to resolve the problems caused by the expansion of fallow fields in North China. Based on a site-specific experiment, temporal and spatial variations of soil NO(3-)-N were investigated during the period from February orchid incorporation to maize harvest. The results showed that the nitrate content in soil profiles not only showed a temporal characteristic, i. e., increasing at the beginning of the maize season and decreasing then after, but also showed a spatial characteristic, i. e., the gradual occurrence of the peak of nitrate content from shallower to deeper layer with the growth season of maize. Meanwhile, incorporation of February orchid could affect temporal and spatial variations of soil NO(3-)-N. February orchid planting reduced the soil NO(3-)-N accumulation in the profile of 0180 cm. After incorporation of February orchid, similar characteristics were observed at the seedling and bell stages of maize, i. e., the soil NO(3-)-N mainly stayed in the profile of 0-20 cm, and NO(3-)-N concentrations in the treatments with February orchid were higher in 0-100 cm layer and lower in 100-180 cm layer than those of the treatments without February orchid. After tasseling stage, opposite phenomena were found, and the soil NO(3-)-N content was all relative low. Overall, incorporation of February orchid could increase the storage capacity of soil NO(3-)-N in the profile of 0-180 cm.
Download full-text PDF |
Source |
---|
PLOS Digit Health
January 2025
UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Patient reported outcome measures (PROMs) capture patients' views of their health status and the use of PROMs as part of standard care of children and young people has the potential to improve communication between patients/carers and clinicians and the quality of care. Electronic systems for the collection of or access to PROMs and integrating PROMs into electronic health records facilitates their implementation in routine care and could help maximise their value. Yet little is known about the technical aspects of implementation including the electronic systems available for collection and capture and how this may influence the value of PROMs in routine care which this scoping review aims to explore.
View Article and Find Full Text PDFSyst Rev
November 2024
Centre for Outcomes and Experience Research in Children's Health, Illness and Disability (ORCHID), Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Background: Patient-reported outcome measures (PROMs) measure people's views of their health status whereas patient-reported experience measures (PREMs) are questionnaires measuring perceptions of their experience whilst receiving healthcare. PROMs/PREMs have the potential to enable children and young people (CYP) to be involved in decisions about their care and improve the quality of their care but it is not clear how often PROMs/PREMs are incorporated as part of standard care of CYP in the hospital setting. The aims of this scoping review were to understand the extent of the literature and map available evidence on the use, benefits, barriers and facilitators of PROMs/PREMs as part of standard care and treatment of CYP in hospitals.
View Article and Find Full Text PDFJ Am Mosq Control Assoc
December 2024
Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Germany.
In February 2024, a resident of Mannheim, Germany, collected aggressively attacking mosquitoes in her home and forwarded them to the "Mueckenatlas" citizen science recording scheme. The specimens turned out to be Aedes albopictus. Upon discussing the situation and consultation on the biology of the Asian tiger mosquito, the submitter found numerous developmental stages in the water of a flowerpot with an orchid in her living room.
View Article and Find Full Text PDFExpert Opin Drug Saf
August 2024
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: Trastuzumab is a humanized monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). This post-marketing surveillance evaluates the safety of a trastuzumab biosimilar (AryoTrust), produced by AryoGen Co. Iran in Iranian women with HER2-positive non-metastatic breast cancer (BC).
View Article and Find Full Text PDFJ Assist Reprod Genet
October 2024
Medical Department, Orchid Reproductive and Andrology Services, Dubai, UAE.
Purpose: To showcase the successful use of ICSI with PGT-M to overcome Beckwith-Wiedemann syndrome (BWS)-related reproductive challenges, resulting in the birth of a healthy baby boy. By targeting the maternally inherited CDKN1C pathogenic gene variant, this report highlights the genetic interventions in BWS reproductive risk management.
Methods: This case report describes a 41-year-old woman seeking fertility assistance after a previous pregnancy revealed a fetal anomaly related to BWS.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!